Somatuline Depot (Ipsen Biopharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Somatuline Depot drug offered from Ipsen Biopharmaceuticals, Inc.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ipsen Biopharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | lanreotide acetate |
SUBSTANCE NAME: | LANREOTIDE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2007-11-14 |
END MARKETING DATE: | 0000-00-00 |
Somatuline Depot HUMAN PRESCRIPTION DRUG Details:
Item Description | Somatuline Depot from Ipsen Biopharmaceuticals, Inc. |
LABELER NAME: | Ipsen Biopharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/.2mL) |
START MARKETING DATE: | 2007-11-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15054-0060_b6a04de9-7836-4ccd-9c34-43ffd7ae403b |
PRODUCT NDC: | 15054-0060 |
APPLICATION NUMBER: | NDA022074 |
Other LANREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers: